Alexander W. Macfarlane

PD-1 Expression on Peripheral Blood Cells Increases with Stage in Renal Cell Carcinoma Patients and Is Rapidly Reduced after Surgical Tumor Resection

Alexander W. Macfarlane, Mowafaq Jillab, Elizabeth R. Plimack et al. · Cancer Immunology Research · 2013 · 166 citations · Full text

Immunology, Pathology, Immunotherapy +17

Application of 3D tumoroid systems to define immune and cytotoxic therapeutic responses based on tumoroid and tissue slice culture molecular signatures

Niklas K. Finnberg, Prashanth Gokare, Avital Lev et al. · Oncotarget · 2017 · 126 citations · Full text

Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell Lymphoma

Stefan K. Barta, Jasmine Zain, Alexander W. Macfarlane et al. · Clinical Lymphoma Myeloma & Leukemia · 2019 · 117 citations · Full text

Lymphoid Neoplasia, Medicine, Immunology +7

B-cell adaptor for PI3K (BCAP) negatively regulates Toll-like receptor signaling through activation of PI3K

Minjian Ni, Alexander W. Macfarlane, Michelle Toft et al. · Proceedings of the National Academy of Sciences · 2011 · 84 citations · Full text

Adaptive Immune System, Innate Immune System, Immunology +27

The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and –independent mechanisms

Tatiana Pazina, Ashley M. James, Alexander W. Macfarlane et al. · OncoImmunology · 2017 · 81 citations · Full text